Aster Capital Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Aster Capital Management's RXST Position: Q1 2026 in Review
Aster Capital Management opened a new position in RxSight (RXST) in Q1 2026: 14 shares worth $354. The stake represents ﹤0.01% of the portfolio and ranks #799 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in RXST as recently as Q1 2025.
Aster Capital Management first reported a position in RXST in Q4 2024 and has held it in 3 quarters since. The position peaked at $52.7K in Q1 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Aster Capital Management held 14 shares of RxSight worth $354 as of Q1 2026.
- RxSight was a new Aster Capital Management position in Q1 2026.
- RxSight made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #799 holding.
- Aster Capital Management first reported a position in RxSight in Q4 2024 and has held it in 3 quarters since.
- Aster Capital Management's RxSight position peaked at $52.7K in Q1 2025.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.